Condition: Hyperinsulinism · Sponsor: Washington University School of Medicine
The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.
This description comes directly from the study's public registry record.
Pamela S Stone, RN · 314-747-4659 · stone.p@wustl.edu
Ana Maria Arbelaez, MD, MSCI · 314-286-1138 · aarbelaez@wustl.edu
Always discuss trial participation with your own doctor first.
| Washington University | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05088798